[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
[] [Item 3.03 Material Modification to Rights of Security Holders. Company Amended and Restated Certificate Amendment of the Series D Certificate of Designation On March 11, 2019, the board of directors of China XD Plastics Company Limited (the “ (d) 3.1 Amendment of the Series D Certificate of Desig]
[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
[] [Item 3.03 Material Modification to Rights of Security Holders. Company Amended and Restated Certificate Amendment of the Series D Certificate of Designation On March 11, 2019, the board of directors of China XD Plastics Company Limited (the “ (d) 3.1 Amendment of the Series D Certificate of Desig]
